First Trust Advisors LP Boosts Stake in ICU Medical, Inc. (ICUI)
First Trust Advisors LP lifted its position in ICU Medical, Inc. (NASDAQ:ICUI) by 38.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,489 shares of the medical instruments supplier’s stock after purchasing an additional 3,209 shares during the quarter. First Trust Advisors LP owned 0.06% of ICU Medical worth $2,135,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of ICU Medical by 10.3% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock worth $122,000 after purchasing an additional 66 shares in the last quarter. Riverhead Capital Management LLC boosted its holdings in shares of ICU Medical by 99.8% in the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 499 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in shares of ICU Medical by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock worth $181,000 after purchasing an additional 157 shares in the last quarter. Parametrica Management Ltd purchased a new position in shares of ICU Medical in the 2nd quarter worth about $213,000. Finally, Teacher Retirement System of Texas purchased a new position in shares of ICU Medical in the 2nd quarter worth about $214,000. Hedge funds and other institutional investors own 74.64% of the company’s stock.
ICUI has been the subject of a number of research reports. BidaskClub cut ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. Zacks Investment Research cut ICU Medical from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 15th. Finally, KeyCorp initiated coverage on ICU Medical in a research note on Tuesday, October 17th. They issued a “sector weight” rating for the company. One analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. ICU Medical has an average rating of “Hold” and an average target price of $232.00.
Shares of ICU Medical, Inc. (NASDAQ:ICUI) opened at $217.90 on Friday. ICU Medical, Inc. has a 52 week low of $127.00 and a 52 week high of $218.45. The company has a quick ratio of 3.01, a current ratio of 4.65 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $4,386.54, a PE ratio of 85.45, a PEG ratio of 3.50 and a beta of 0.33.
ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, November 9th. The medical instruments supplier reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.77 by $0.35. ICU Medical had a return on equity of 4.81% and a net margin of 2.79%. The company had revenue of $343.20 million during the quarter, compared to analyst estimates of $328.56 million. During the same quarter in the previous year, the company posted $1.35 EPS. ICU Medical’s revenue for the quarter was up 253.5% on a year-over-year basis. analysts expect that ICU Medical, Inc. will post 3.95 earnings per share for the current year.
In other news, Director Joseph R. Saucedo sold 2,000 shares of the business’s stock in a transaction dated Tuesday, November 21st. The stock was sold at an average price of $216.06, for a total value of $432,120.00. Following the completion of the sale, the director now owns 554,364 shares of the company’s stock, valued at approximately $119,775,885.84. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Chairman Vivek Jain sold 97,795 shares of the business’s stock in a transaction dated Friday, October 20th. The shares were sold at an average price of $190.00, for a total value of $18,581,050.00. Following the completion of the sale, the chairman now directly owns 67,680 shares of the company’s stock, valued at approximately $12,859,200. The disclosure for this sale can be found here. In the last three months, insiders sold 127,247 shares of company stock valued at $24,170,158. 13.60% of the stock is currently owned by corporate insiders.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.